Tanja Rothhammer-Hampl

Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen.

Helmut Oettle, Thomas Seufferlein, Thomas A. Luger et al. · Journal of Clinical Oncology · 2012 · 53 citations

Medicine, Oncology, Pharmacology +16

Quantification of Oligonucleotides by LC–MS/MS: The Challenges of Quantifying A Phosphorothioate Oligonucleotide and Multiple Metabolites

Matthew Ewles, Lee Goodwin, Anneliese Schneider et al. · Bioanalysis · 2014 · 52 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +17

Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties

Julian Triebelhorn, Iseline Cardon, Kerstin Kuffner et al. · Molecular Psychiatry · 2022 · 30 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology

Julia Lorenz, Tanja Rothhammer-Hampl, Saida Zoubaa et al. · Acta Neuropathologica Communications · 2020 · 27 citations · Full text

Medicine, Genetics, Oncology +17

Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions

Markus Schulze, Maria Hutterer, Anja Sabo et al. · BMC Cancer · 2018 · 26 citations · Full text

Medicine, Cell Biology, Oncology +16